Purchase Order 75N92021P00054
Award Date 1/19/21
Potential Completion Date 1/18/22
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60654, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics through...
- The National Heart Lung and Blood Institute (NHLBI), a civilian federal agency, awarded a $250,000 firm fixed-price purchase order to Ascella Biosystems Inc. on January 13, 2021, for support services under the RADX-TECH Work Package 1 initiative. The contract, which was not designated as a set-aside, carried an ultimate completion date of January 12, 2022, and identified performance location in Fremont, California. This award was designated as a National Interest Action related to coronavirus...
- The National Institutes of Health National Heart Lung and Blood Institute awarded a $14.9 million purchase order contract to the National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, to provide infrastructure support for the Rapid Acceleration of Diagnostics Initiative. The one-year, time and materials contract will support the NIH's RADX program, which aims to accelerate the development, commercialization, and implementation of novel diagnostics...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley, Massachusetts. The $2,097,064.03 firm fixed-price delivery order is for clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) initiative, which aims to...
- The Department of Health and Human Services National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $20.7 million firm fixed price definitive contract to Associated Pathologists, LLC (doing business as Pathgroup) for the Rapid Acceleration of Diagnostics (RADX) ATP Program - Project #7338. The contract is being funded under the Coronavirus COVID-19 national interest action code and will support RADX's goal of accelerating the development,...
- This federal contract award, valued at $10,691,445.48, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government, to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract is for Rapid Acceleration of Diagnostics (RADx) Clinical Evaluation Services (CES) - Task Order 9. Venturewell has extensive experience managing federal contracts and grants focused on advancing...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1.5 million firm fixed-price contract to Palogen, Inc. on September 30, 2021, for the RADX Tech 2 Project Number 13139. This definitive contract supports the development of innovative ultra-fast chip technology for COVID-19 RNA detection, with work performed in South Korea. The contract was completed on September 29, 2023, and no small business set-aside was utilized for this award. Palogen's technology development effort aligns...
- This is a $3,179,063.00 firm fixed-price delivery order contract awarded by the National Institutes of Health (NIH) National Heart Lung and Blood Institute to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell). The contract provides clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development of innovative COVID-19 detection technologies and other diagnostic platforms....
- This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract is for $7,728,469.00 and is for clinical evaluation services related to the Rapid Acceleration of Diagnostics (RADx) initiative, which supports the development and validation of innovative diagnostic...
- This is a delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract, valued at $2,929,804.60, is for clinical evaluation services in support of the Rapid Acceleration of Diagnostics (RADx) initiative, specifically for RADx projects 6818 and 13379. This contract is not a...
The Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute awarded a $250,000 firm fixed price purchase order to Arete Biosciences, LLC of Chicago, Illinois. The contract is to support the Rapid Acceleration of Diagnostics (RADX) Program Technology effort through January 18, 2022. No major subcontractors or set aside designations were indicated. The award provides funding for Arete Biosciences to likely deliver diagnostic technologies or services to the NIH's RADX Program, which aims to speed innovation in the development and commercialization of COVID-19 testing technologies.
Generated 12/30/23, 9:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 11/15/21 | |
| Not listed | Not listed | $250.0k | 1/19/21 |